Safety and Efficacy of Baricitinib in Elderly Patients with Moderate to Severe Rheumatoid Arthritis

被引：0
|
作者：
Fleischmann, Roy [1 ,2 ]
Alam, Jahangir [3 ]
Arora, Vipin [3 ]
Bradley, John D. [3 ]
Schlichting, Douglas E. [3 ]
Muram, David [3 ]
机构：
[1] Metroplex Clin Res Ctr, Dallas, TX USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1590
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Safety of Baricitinib 4 mg for the Treatment of Moderate to Severe Rheumatoid Arthritis
    Dabal, Tracey D.
    Haltom, Matthew B.
    Patel, Puja P.
    Son, Christine K.
    Joglekar, Kiran P.
    Groeschell, Charles M.
    Chumpia, Mason M.
    Kamal, Sehrish F.
    Seth, Ankur
    Jackson, Christopher D.
    [J]. SOUTHERN MEDICAL JOURNAL, 2021, 114 (05) : 288 - 292
  • [2] Herpes Zoster in Patients with Moderate to Severe Rheumatoid Arthritis Treated with Baricitinib
    Winthrop, Kevin L.
    Lindsey, Stephen
    Weinblatt, Michael
    Takeuchi, Tsutomu
    Hyslop, David
    Issa, Maher
    Chen, Lei
    Bradley, John
    Dickson, Christina
    Fleischmann, Roy
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [3] The safety of baricitinib in patients with rheumatoid arthritis
    Honda, Suguru
    Harigai, Masayoshi
    [J]. EXPERT OPINION ON DRUG SAFETY, 2020, 19 (05) : 545 - 551
  • [4] EFFICACY AND SAFETY OF BARICITINIB IN JAPANESE RHEUMATOID ARTHRITIS PATIENTS AT 12 WEEKS
    Tanaka, Y.
    Emoto, K.
    Tsujimoto, M.
    Schlichting, D.
    Macias, W.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 231 - 231
  • [5] Efficacy and safety of tocilizumab in elderly patients with rheumatoid arthritis
    Pers, Yves-Marie
    Schaub, Roxane
    Constant, Elodie
    Lambert, Joseph
    Godfrin-Valnet, Marie
    Fortunet, Clementine
    Bourichi, Waafa
    Prades, Beatrice Pallot
    Wendling, Daniel
    Gaudin, Philippe
    Jorgensen, Christian
    Maillefert, Jean-Francis
    Marotte, Hubert
    [J]. JOINT BONE SPINE, 2015, 82 (01) : 25 - 30
  • [6] EFFICACY AND SAFETY OF TOCILIZUMAB IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS
    Pers, Y. -M.
    Schaub, R.
    Fortunet, C.
    Constant, E.
    Lambert, J.
    Godfrin-Valnet, M.
    Pallot-Prades, B.
    Wendling, D.
    Gaudin, P.
    Marotte, H.
    Maillefert, J. -F.
    Jorgensen, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 689 - 689
  • [7] Effect of Baricitinib on Joint-Related Biomarkers in Patients with Moderate-to-Severe Rheumatoid Arthritis
    Thudium, Christian S.
    Bay-Jensen, Anne C.
    Cahya, Suntara
    Dow, Ernst R.
    Karsdal, Morten A.
    Koch, Alisa E.
    Zhang, Wenling
    Benschop, Robert J.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [8] SERIOUS INFECTION AND ASSOCIATED RISK FACTORS IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS TREATED WITH BARICITINIB
    Winthrop, K. L.
    Genovese, M. C.
    Harigai, M.
    Chen, L.
    Dickson, C. L.
    Hyslop, D. L.
    Nishikawa, A.
    Bradley, J. D.
    Dougados, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 158 - 158
  • [9] BARICITINIB IN THE TREATMENT OF PATIENTS WITH MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS IN CHINA: 24-WEEK RESULTS OF POSTMARKETING SAFETY STUDY
    Wu, C. Y.
    Wang, Q.
    Shi, J.
    Zhang, X.
    Du, R.
    Gu, J.
    Liu, Q. H.
    Yu, J.
    Xu, J. W.
    Zhang, Y. J.
    Zhu, H.
    Li, M.
    Zeng, X.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1418 - 1418
  • [10] Rapid Onset of Efficacy of Baricitinib in Chinese Patients with Moderate to Severe Rheumatoid Arthritis: Results from Study RA-BALANCE
    Li, Zhan-Guo
    Hu, Jian-Kang
    Li, Xiang-Pei
    Yang, Yue
    Li, Xing-Fu
    Xu, Jian-Hua
    Zhang, Xiao
    Xu, Jian
    Bao, Chun-De
    He, Dong-Yi
    Li, Zhi-Jun
    Wang, Guo-Chun
    Zuo, Xiao-Xia
    Liu, Yi
    Xiao, Zheng-Yu
    Chen, Jin-Wei
    Xin, Xia-Fei
    Li, Jing-Yang
    Jiang, Lin-Di
    Liu, Meng-Ru
    Ji, Fei
    Li, Chen-Ge
    [J]. ADVANCES IN THERAPY, 2021, 38 (01) : 772 - 781
12345